Cutler Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
GIM
PAI
TCM
Cutler Group's BLUE Position: Q1 2024 in Review
Cutler Group held its bluebird bio (BLUE) position steady in Q1 2024 at 40 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1952.
Cutler Group first reported a position in BLUE in Q4 2015 and has held it in 22 quarters since. The position peaked at $3.52M in Q4 2015. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.
- Cutler Group held 40 shares of bluebird bio worth $1K as of Q1 2024.
- Cutler Group left its bluebird bio share count unchanged in Q1 2024.
- bluebird bio made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1952 holding.
- Cutler Group first reported a position in bluebird bio in Q4 2015 and has held it in 22 quarters since.
- Cutler Group's bluebird bio position peaked at $3.52M in Q4 2015.
- 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.